Shigatoxin-1 binding and receptor expression in human kidneys do not change with age

Pediatric Nephrology

Volumn 18, Issue 3, 2003, Pages 246-253

  Ergonul, Zuhal ^a   Clayton, Frederic ^a   Fogo, Agnes B ^b   Kohan, Donald E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adults; Children; Gb3; Hemolytic uremic syndrome; Renal

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; SHIGA TOXIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BINDING SITE; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; THIN LAYER CHROMATOGRAPHY;

EID: 0037484358     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-1025-9     Document Type: Article

References (21)

1. Remuzzi G, Ruggenenti P, Bertani T (1994) Thrombotic microangiopathy. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. JB Lippincott, Philadelphia, pp 1154-1184
2. Robson WL, Leung AK (1993) The hemolytic-uremic syndrome and Escherichia coli 0157:H7 infection. Ann Intern Med 119:249-250
3. Siegler R, Pavia A, Christofferson R, Milligan M (1994) A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94:35-40
4. Siegler RL (1995) The hemolytic uremic syndrome. Ped Nephrol 42:1505-1529
5. Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831-846
6. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO (1993) Endothelial heterogeneity in shiga toxin receptors and responses. J Biol Chem 268:15484-15488
7. van de Kar N, Monnens LAH, Karmali MA, van Hinsbergh VWM (1992) Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764
8. van de Kar N, Kooistra T, Vermeer M, Lesslauer W, Monnens LAH, van Hinsbergh VWM (1995) Tumor necrosis factor α induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood 85:734-743
9. van Setten P, van Hinsbergh V, van der Velden T, van de Kar N, Vermeer M, Mahan J, Assmann K, van den Heuvel L, Monnens L (1997) Effects of TNFα on verocytotoxin cytotoxicity in purified glomerular microvascular endothelial cells. Kidney Int 51:1245-1256
10. Boyd B, Lingwood C (1989) Verotoxin receptor glycolipid in human renal tissue. Nephron 51:207-210
11. Lingwood CA (1994) Verotoxin-binding in human renal sections. Nephron 66:21-28
12. Strockbine N, Marques L, Holmes R, O'Brian A (1985) Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun 50:695-700
13. Hughes A, Stricklett P, Kohan D (1998) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54:426-437
14. Arab S, Lingwood C (1998) Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646-660
15. Lingwood C (1993) Verotoxins and their glycolipid receptors. Adv Lipid Res 25:189-211
16. Louise CB, Obrig TG (1995) Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397-1401
17. Hashimoto H, Mizukoshi K, Nishi M, Kawakita T, Hasui S, Kato Y, Ueno Y, Takeya R, Okuda N, Takeda T (1999) Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan. Pediatrics 103:E2
18. Jacewicz MS, Acheson DWK, Binion DG, West GA, Lincicome LL, Fiocchi C, Keusch GT (1999) Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun 67:1439-1444
19. Te Loo D, van Hinsbergh V, van den Heuvel L, Monnens L (2001) Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol 12:800-806
20. Simon M, Cleary TG, Hernandez JD, Abboud HE (1998) Shiga toxin 1 elicits diverse biologic responses in mesangial cells. Kidney Int 54:1117-1127
21. Foster GH, Armstrong CS, Sakiri R, Tesh VL (2000) Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect Immun 68:5183-5189